Castle Biosciences, Inc. (CSTL)
USD 19.35
(0.21%)
USD 19.35
(0.21%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -67.97 Million USD | 25.42% |
| 2022 | -91.14 Million USD | -127.41% |
| 2021 | -40.07 Million USD | -512.64% |
| 2020 | -6.54 Million USD | -238.98% |
| 2019 | 4.7 Million USD | 222.72% |
| 2018 | -3.83 Million USD | 64.81% |
| 2017 | -10.89 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 5.07 Million USD | 1.34% |
| 2024 Q2 | 5.01 Million USD | 191.61% |
| 2024 Q1 | -5.47 Million USD | 3.31% |
| 2023 Q2 | -21.15 Million USD | 32.88% |
| 2023 Q1 | -31.52 Million USD | -36.27% |
| 2023 FY | -67.97 Million USD | 25.42% |
| 2023 Q4 | -5.65 Million USD | 41.31% |
| 2023 Q3 | -9.64 Million USD | 54.44% |
| 2022 Q3 | -21.68 Million USD | 11.01% |
| 2022 Q2 | -24.36 Million USD | 0.6% |
| 2022 Q1 | -24.51 Million USD | -61.6% |
| 2022 FY | -91.14 Million USD | -127.41% |
| 2022 Q4 | -23.13 Million USD | -6.66% |
| 2021 Q1 | -4.28 Million USD | -41.29% |
| 2021 Q2 | -8.81 Million USD | -105.65% |
| 2021 Q3 | -11.81 Million USD | -34.1% |
| 2021 FY | -40.07 Million USD | -512.64% |
| 2021 Q4 | -15.17 Million USD | -28.42% |
| 2020 FY | -6.54 Million USD | -238.98% |
| 2020 Q2 | -645 Thousand USD | -162.26% |
| 2020 Q1 | 1.03 Million USD | -60.35% |
| 2020 Q4 | -3.03 Million USD | 22.28% |
| 2020 Q3 | -3.9 Million USD | -504.81% |
| 2019 Q1 | -321.44 Thousand USD | -106.74% |
| 2019 Q4 | 2.61 Million USD | -41.01% |
| 2019 FY | 4.7 Million USD | 222.72% |
| 2019 Q3 | 4.42 Million USD | 628.94% |
| 2019 Q2 | 607.62 Thousand USD | 289.03% |
| 2018 Q2 | -2.66 Million USD | 13.57% |
| 2018 Q4 | 4.76 Million USD | 267.18% |
| 2018 Q1 | -3.08 Million USD | 0.0% |
| 2018 FY | -3.83 Million USD | 64.81% |
| 2018 Q3 | -2.85 Million USD | -6.95% |
| 2017 FY | -10.89 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | -97.35 Million USD | 30.178% |
| Biodesix, Inc. | -41.34 Million USD | -64.426% |
| bioAffinity Technologies, Inc. | -7.97 Million USD | -752.566% |
| DarioHealth Corp. | -56.18 Million USD | -20.979% |
| Exact Sciences Corporation | -215.01 Million USD | 68.385% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | 106.196% |
| Illumina, Inc. | -1.06 Billion USD | 93.641% |
| Intelligent Bio Solutions Inc. | -10.28 Million USD | -561.051% |
| iSpecimen Inc. | -11.16 Million USD | -508.603% |
| Standard BioTools Inc. | -76.6 Million USD | 11.257% |
| 23andMe Holding Co. | -321.35 Million USD | 78.847% |
| Medpace Holdings, Inc. | 336.82 Million USD | 120.182% |
| NeoGenomics, Inc. | -107.73 Million USD | 36.904% |
| Inotiv, Inc. | -81.46 Million USD | 16.552% |
| Psychemedics Corporation | -2.92 Million USD | -2227.182% |
| Prenetics Global Limited | -52.51 Million USD | -29.447% |
| Precipio, Inc. | -7.62 Million USD | -792.087% |
| RadNet, Inc. | 98.69 Million USD | 168.874% |
| Sotera Health Company | 276.69 Million USD | 124.568% |
| Star Equity Holdings, Inc. | -4.34 Million USD | -1464.128% |
| Exagen Inc. | -22.83 Million USD | -197.662% |
| Natera, Inc. | -446.24 Million USD | 84.767% |
| Aspira Women's Health Inc. | -18.85 Million USD | -260.582% |
| Neogen Corporation | 58.66 Million USD | 215.877% |
| Myriad Genetics, Inc. | -123.7 Million USD | 45.047% |
| ICON Public Limited Company | 956.15 Million USD | 107.109% |
| Bionano Genomics, Inc. | -215.24 Million USD | 68.419% |
| CareDx, Inc | -101.9 Million USD | 33.29% |
| Check-Cap Ltd. | -19.28 Million USD | -252.45% |
| Twist Bioscience Corporation | -220.83 Million USD | 69.218% |
| Guardant Health, Inc. | -564.72 Million USD | 87.963% |
| BioNexus Gene Lab Corp. | -2.59 Million USD | -2520.964% |
| Fulgent Genetics, Inc. | -72.69 Million USD | 6.49% |
| Sera Prognostics, Inc. | -39.82 Million USD | -70.706% |
| OPKO Health, Inc. | -157.02 Million USD | 56.708% |
| Personalis, Inc. | -109.93 Million USD | 38.167% |
| Applied DNA Sciences, Inc. | -10.95 Million USD | -520.608% |
| Star Equity Holdings, Inc. | -4.34 Million USD | -1464.128% |
| MDxHealth SA | -27.32 Million USD | -148.754% |
| Prenetics Global Limited | -52.51 Million USD | -29.447% |
| ENDRA Life Sciences Inc. | -10.52 Million USD | -546.124% |
| Mainz Biomed B.V. | -26.64 Million USD | -155.124% |
| Trinity Biotech plc | -27.04 Million USD | -151.348% |
| Neuronetics, Inc. | -30.55 Million USD | -122.482% |
| bioAffinity Technologies, Inc. | -7.97 Million USD | -752.566% |